| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM701522B |
| P698 | PubMed publication ID | 18412318 |
| P2093 | author name string | Hongyan Li | |
| Leszek Poppe | |||
| Ankita Patel | |||
| Murielle M Véniant | |||
| Colin V Gegg | |||
| Mark Ma | |||
| Jingwen Zhang | |||
| Mark J Rose | |||
| Jason Long | |||
| Shanaka Stanislaus | |||
| Les P Miranda | |||
| Stephanie Diamond | |||
| Mark Guido | |||
| Jennifer Aral | |||
| Katherine A Winters | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2758-2765 | |
| P577 | publication date | 2008-04-15 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity | |
| P478 | volume | 51 |
| Q42280003 | A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection |
| Q42002273 | A hydrophobic site on the GLP-1 receptor extracellular domain orients the peptide ligand for signal transduction |
| Q34282783 | A potent α/β-peptide analogue of GLP-1 with prolonged action in vivo |
| Q38864019 | Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1. |
| Q30367509 | Constraining cyclic peptides to mimic protein structure motifs. |
| Q27657999 | Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor |
| Q49608912 | Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr(allyl). |
| Q35150480 | Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis |
| Q46196565 | Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS. |
| Q53241623 | Functional association of the N-terminal residues with the central region in glucagon-related peptides. |
| Q112989493 | GLP1R binds GLP1R agonists |
| Q42963582 | Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor |
| Q28067465 | Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes |
| Q35087846 | Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications. |
| Q42557469 | Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells |
| Q36637567 | Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control |
| Q35226241 | Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist |
| Q90027405 | Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery |
| Q34953338 | Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability |
| Q89715710 | One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer |
| Q38068571 | Peptide scanning for studying structure-activity relationships in drug discovery |
| Q64106173 | Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo |
| Q27679468 | Structure-Guided Rational Design of α/β-Peptide Foldamers with High Affinity for BCL-2 Family Prosurvival Proteins |
| Q95643214 | The activity of sulfono-γ-AApeptide helical foldamers that mimic GLP-1 |
| Q39426260 | Trichogin GA IV: a versatile template for the synthesis of novel peptaibiotics. |
| Q42408374 | Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro. |
Search more.